Acute exacerbation of chronic bronchitis: disease-specific issues that influence the cost-effectiveness of antimicrobial therapy

Clinical Therapeutics
S SaintA M Fendrick

Abstract

Acute exacerbation of chronic bronchitis (AECB) is a common condition, with substantial associated costs and morbidity. Research efforts have focused on innovations that will reduce the morbidity associated with AECB. Health care payers increasingly expect that the results of evidence-based economic evaluations will guide practitioners in their choice of cost-effective interventions. To provide a framework on which to base effective and efficient antimicrobial therapy for AECB, we present a concise clinical review of AECB, followed by an assessment of the available data on the economic impact of this disease. We then address several AECB-specific issues that must be considered in cost-effectiveness analyses of AECB antimicrobial interventions. Published literature on the clinical and economic impact of AECB was identified using MEDLINE, pre-MEDLINE, HealthSTAR, CINAHL, Current Contents/All Editions, EMBASE, and International Pharmaceutical Abstracts databases. Other potential sources were identified by searching for references in retrieved articles, review articles, consensus statements, and articles written by selected authorities. In evaluating cost-effectiveness analyses of AECB antimicrobial therapy it is critical to (1) us...Continue Reading

References

Apr 1, 1978·The Journal of Infectious Diseases·R O BuschoM A Mufson
Oct 1, 1992·The American Review of Respiratory Disease·T F Murphy, S Sethi
Feb 1, 1987·Annals of Internal Medicine·N R AnthonisenN A Nelson
Aug 1, 1995·Chest·R Wilson
Dec 24, 1997·Chest·R Wilson, C B Wilson
Oct 21, 1998·Infectious Disease Clinics of North America·M Niroumand, R F Grossman
Nov 3, 1998·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·S ChodoshS Kowalsky
Nov 3, 1998·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·G V DoernR N Jones
Jan 5, 1999·American Journal of Respiratory and Critical Care Medicine·R KesslerE Weitzenblum
May 4, 1999·The Journal of Antimicrobial Chemotherapy·S Sethi
May 4, 1999·The Journal of Antimicrobial Chemotherapy·C J DestacheV A Angelillo
May 13, 1999·Clinical Therapeutics·M S NiedermanR Popovian
Jul 3, 1999·American Journal of Respiratory and Critical Care Medicine·N MogulkocN Colpan
Aug 18, 1999·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·A AnzuetoR F Grossman
Nov 24, 1999·The American Journal of Medicine·J S HongJ B Schorling
Nov 26, 1999·Journal of General Internal Medicine·A A WilsonR Gonzales
Feb 16, 2000·Chest·S D SullivanT A Lee
Mar 17, 2000·The Journal of Antimicrobial Chemotherapy·P Nicolson, P Anderson
Apr 5, 2000·Seminars in Respiratory Infections·R F Grossman
Jun 10, 2000·Chest·N F Voelkel, R Tuder

❮ Previous
Next ❯

Citations

May 28, 2004·Comprehensive Therapy·Fernando J Martinez
Jun 26, 2009·International Journal of Chronic Obstructive Pulmonary Disease·Sean H Ling, Stephan F van Eeden
Nov 13, 2002·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·Joshua P Metlay, Daniel E Singer
Nov 5, 2003·Pharmacotherapy·Michele A Faulkner, Daniel E Hilleman
Feb 28, 2002·Expert Opinion on Pharmacotherapy·Michele A Faulkner, Daniel E Hilleman
Oct 22, 2002·Expert Opinion on Pharmacotherapy·Demet Karnak, Sumru Beder
May 3, 2006·Respiratory Medicine·Steven SimoensGert Laekeman
Jan 31, 2006·Expert Review of Anti-infective Therapy·Fernando J MartinezJeffrey Curtis
Mar 18, 2006·International Journal of Antimicrobial Agents·Fernando J Martinez
Feb 9, 2012·Expert Review of Vaccines·Angel Vila-Corcoles, Olga Ochoa-Gondar

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.